US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: by Athena L. Huang, MD, Ann Marie Navar, MD, PhD, Colby Ayers, MS, Anand Rohatgi, MD, MSCS, Erin Michos, MD, MHS, Salim Virani, MD, PhD, Parag Joshi, MD, MHS, Eric Peterson, MD, MPH, Amit Khera, MD, MSc

Get full text